Authors: Sawyer, T Boyce, B Dalgarno, D Iuliucci, J

Citation: T. Sawyer et al., Src inhibitors: genomics to therapeutics, EXPERT OP I, 10(7), 2001, pp. 1327-1344

Authors: Iuliucci, JD Oliver, SD Morley, S Ward, C Ward, J Dalgarno, D Clackson, T Berger, HJ

Citation: Jd. Iuliucci et al., Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903,in healthy volunteers, J CLIN PHAR, 41(8), 2001, pp. 870-879

Authors: Shakespeare, W Yang, M Bohacek, R Cerasoli, F Stebbins, K Sundaramoorthi, R Azimioara, M Vu, C Pradeepan, S Metcalf, C Haraldson, C Merry, T Dalgarno, D Narula, S Hatada, M Lu, XD van Schravendijk, MR Adams, S Violette, S Smith, J Guan, W Bartlett, C Herson, J Iuliucci, J Weigele, M Sawyer, T

Citation: W. Shakespeare et al., Structure-based design of an osteoclast-selective, nonpeptide Src homology2 inhibitor with in vivo antiresorptive activity, P NAS US, 97(17), 2000, pp. 9373-9378

Authors: Yang, W Rozamus, LW Narula, S Rollins, CT Yuan, R Andrade, LJ Ram, MK Phillips, TB van Schravendijk, MR Dalgarno, D Clackson, T Holt, DA

Citation: W. Yang et al., Investigating protein-ligand interactions with a mutant FKBP possessing a designed specificity pocket, J MED CHEM, 43(6), 2000, pp. 1135-1142

Authors: Yang, W Digits, CA Hatada, M Narula, S Rozamus, LW Huestis, CM Wong, J Dalgarno, D Holt, DA

Citation: W. Yang et al., Selective epimerization of rapamycin via a retroaldol/aldol mechanism mediated by titanium tetraisopropoxide, ORG LETT, 1(12), 1999, pp. 2033-2035